封面
市場調查報告書
商品編碼
1855841

2025年全球造影劑注射線市場報告

Contrast Injection Lines Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,造影劑注射管路市場規模呈現強勁成長,從2024年的36.6億美元成長到2025年的39.3億美元,複合年成長率達7.2%。這段期間的成長可歸因於以下因素:人們對微創手術的偏好日益成長;對疾病早期檢測和篩檢意識的提高;手術計劃中對精確即時成像的需求不斷成長;神經系統和心血管成像對造影劑的需求不斷增加;以及政府對診斷程序的支持和報銷力度加大。

預計未來幾年造影劑注射管路市場規模將強勁成長,2029年將達到51.2億美元,複合年成長率(CAGR)為6.8%。預測期內的成長主要受以下因素驅動:慢性病盛行率上升、醫療基礎設施投資增加、放射科中心和診斷診所數量增加以及老年人口不斷擴大。預測期內的關鍵趨勢包括:高壓造影注射系統的技術進步、注射器技術的進步、與成像平台的整合、高壓管路的開發以及智慧造影輸送系統的創新。

造影輸注管路是醫學影像中用於將造影劑直接輸送到患者血液中的專用管路系統。其主要功能是提高血管、組織和器官的顯影效果,以達到更準確的診斷。這些管路的設計旨在精確控制造影劑的流量和壓力,同時確保患者安全並降低污染或洩漏的風險。

造影注射管路主要分為高壓造影管路及低壓造影管路。高壓造影管路是一種耐用的醫用導管,設計用於在診斷成像過程中以高壓輸注造影劑。產品包括非離子型、離子型、鋇造影和钆基造影造影,可經由靜脈、動脈、口服或鞘內途徑給藥。這些管路廣泛應用於醫院、影像造影中心、專科診所和研究機構,用於各種檢查,包括磁振造影、X光、電腦斷層掃描(CT)和血管造影術。

美國關稅的快速上漲以及持續到2025年春季的貿易摩擦,對醫療設備行業產生了重大影響,尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所抵制價格上漲,擠壓了製造商的淨利率。監管障礙加劇了這個問題,因為與關稅相關的供應商變更通常需要重新認證設備,從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司(The Business Research Company)最新系列報告的一部分,提供造影注射管市場統計數據,包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、造影的市場細分、市場趨勢和商機,以及您在造影注射管行業取得成功所需的數據。本造影造影管市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析,為您提供所需的一切觀點。

影像檢查的增加推動了造影注射管市場的成長。診斷影像是一種用於可視化體內結構的醫學技術,有助於診斷、監測和治療各種健康狀況。這些檢查的增加主要是由於慢性疾病的日益普遍,而這些疾病需要準確且持續的內部評估才能進行有效治療。造影注射管在這些檢查中發揮著至關重要的作用,它能夠以可控且精確的方式輸送造影劑,從而增強掃描過程中組織、血管和其他異常情況的可見度。這提高了診斷的準確性和工作流程效率,同時最大限度地減少了人工操作,並支援更安全、無污染的給藥方式。例如,英國國家醫療服務體系 (NHS) 在 2023 年 5 月報告稱,全科醫生轉診的腦部磁振造影檢查數量從 2022 年 1 月的 8,695 例增加到 2023 年 1 月的 8,745 例。診斷影像的增加正在推動對造影注射管的需求。

該市場中的公司正致力於技術創新,例如開發先進的磁振造影造影,以提高診斷成像的準確性和工作流程效率。這些注射器是一種專用設備,旨在在磁振造影 (MRI) 過程中自動將造影注入患者血液,從而增強掃描影像中內部結構的可見度。 2025 年 5 月,總部位於美國的放射學公司 Bracco Diagnostics Inc. 推出了 Max 3 無針注射器系統,提高了造影注射的安全性和效率。該系統無需使用注射器即可直接從造影管瓶注射,從而加快患者轉移速度並減少材料浪費。該系統可在高達 50 毫特斯拉的磁振造影環境中無線運行,其 EasyClick 盒式連接器和 SafeConnect 技術可實現靈活的放置以及安全、防污染的連接。該系統旨在提高 MRI 掃描過程中造影造影給藥的工作流程效率、增強患者安全性並兼顧環境因素。

2022年11月,總部位於美國的醫療科技公司GE醫療科技與德國Ulrich GmbH and Company KG公司達成夥伴關係。此次合作旨在透過使用無針造影劑造影來提高美國電腦斷層掃描(CT)的效率,從而減少浪費並提高患者吞吐量。 Ulrich GmbH and Company KG是一家總部位於德國的科技公司,專門造影注射系統的研發和生產。

造影注射管路市場包括Y型接頭管路組件、止回閥管路、高壓延長管、導管以及用於造影注射的相關配件的銷售。該市場的價值為“出廠價”,即製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的商品價值。該市場商品價值還包括製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通貨膨脹、地緣政治、貿易戰和關稅,以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球造影注射線:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 終端用戶產業分析
  • 全球造影注射線市場:成長率分析
  • 全球造影注射線市場表現:規模與成長,2019-2024年
  • 全球造影注射線市場預測:規模與成長,2024-2029年,2034年預測
  • 全球造影注射生產線:潛在市場規模 (TAM)

第6章 市場細分

  • 全球造影注射管線市場:按類型、性能和預測分類,2019-2024年、2024-2029年預測、2034年預測
  • 高壓造影注射管
  • 低壓造影注射管
  • 全球造影注射管線市場:依產品類型、性能及預測分類,2019-2024年、2024-2029年預測、2034年預測
  • 非離子型造影劑
  • 離子型造影劑
  • 鋇基造影劑
  • 钆基造影劑
  • 全球造影劑注射管線市場:依給藥途徑分類,實際值及預測值,2019-2024年、2024-2029年預測值、2034年預測值
  • 靜脈注射
  • 動脈內注射
  • 口服
  • 鞘內注射
  • 全球造影注射管線市場:依應用、效能和預測分類,2019-2024年、2024-2029年預測、2034年預測
  • 磁振造影
  • X光
  • 電腦斷層掃描(CT)
  • 血管造影術
  • 其他用途
  • 全球造影注射管線市場:依最終使用者、效能和預測分類,2019-2024年、2024-2029年預測、2034年預測
  • 醫院
  • 診斷影像中心
  • 專科診所
  • 研究所
  • 全球造影注射管線市場:細分市場 高壓造影注射管線:按類型、性能和預測分類,2019-2024年、2024-2029年預測、2034年預測
  • 血管造影術用高壓管路
  • 一次高壓管路
  • 雙腔高壓管
  • 全球造影注射管線市場:細分市場 低壓造影造影注射管線:按類型分類,實際數據和預測數據,2019-2024年、2024-2029年預測數據、2034年預測數據
  • 手動注射管
  • 可重複使用的低壓管
  • 基於注射器的低壓管路

第7章 區域和國家分析

  • 全球造影注射管線市場:依地區、績效及預測分類,2019-2024年、2024-2029年預測、2034年預測
  • 全球造影注射管線市場:按國家/地區、性能和預測分類,2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章:西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章:俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 造影劑注射線市場:競爭格局
  • 造影劑注射線市場:公司簡介
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bracco Imaging SpA Overview, Products and Services, Strategy and Financial Analysis
    • Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Guerbet Group Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • B. Braun SE
  • ACIST Medical Systems Inc.
  • ulrich medical
  • Sino Medical-Device Technology Co. Ltd.
  • VIVID Imaging Pvt. Ltd.
  • Medex
  • Hemant Surgical Industries Limited
  • Medtron AG
  • Argon Medical Devices Inc.
  • Apollo RT
  • George Philips Medical Engineering Pvt. Ltd.
  • Nemoto Kyorindo Co. Ltd.
  • Sequoia Healthcare Limited
  • Shenzhen Anke High-Tech Co. Ltd.
  • Shenzhen Kenid Medical Devices Co. Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章:高潛力市場國家、細分市場與策略

  • 2029年造影劑注射線市場:提供新機會的國家
  • 2029年造影劑注射管線市場:新興細分市場機會
  • 2029年造影劑注射線市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38490

Contrast injection lines are specialized tubing systems used in medical imaging procedures to deliver contrast agents directly into a patient's bloodstream. Their main function is to improve the visibility of blood vessels, tissues, or organs, enabling more accurate diagnoses. These lines are engineered to manage precise flow rates and pressures of contrast material while ensuring patient safety and reducing the risk of contamination or leakage.

The primary types of contrast injection lines are high-pressure contrast injection lines and low-pressure contrast injection lines. A high-pressure contrast injection line is a durable medical tube designed to administer contrast media at high pressure during diagnostic imaging procedures. Product categories include non-ionic contrast media, ionic contrast media, barium-based contrast agents, and gadolinium-based contrast agents, which are delivered through intravenous injection, intra-arterial injection, oral administration, and intrathecal injection. These lines are applied across various procedures such as magnetic resonance imaging, X-ray examinations, computed tomography (CT) scans, angiography, and others, and are widely used by hospitals, diagnostic imaging centers, specialty clinics, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The contrast injection lines market research report is one of a series of new reports from The Business Research Company that provides contrast injection lines market statistics, including contrast injection lines industry global market size, regional shares, competitors with a contrast injection lines market share, detailed contrast injection lines market segments, market trends and opportunities, and any further data you may need to thrive in the contrast injection lines industry. This contrast injection lines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contrast injection lines market size has grown strongly in recent years. It will grow from $3.66 billion in 2024 to $3.93 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period is attributed to the increasing preference for minimally invasive procedures, rising awareness of early disease detection and screening, the growing need for accurate and real-time imaging in surgical planning, higher demand for contrast media in neurological and cardiovascular imaging, and greater government support and reimbursement for diagnostic procedures.

The contrast injection lines market size is expected to see strong growth in the next few years. It will grow to $5.12 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth during the forecast period is driven by the rising prevalence of chronic diseases, increasing investments in healthcare infrastructure, the growing number of radiology centers and diagnostic clinics, and the expanding geriatric population. Key trends in the forecast period include technological advancements in high-pressure contrast injection systems, progress in injector technology, integration with imaging platforms, development of high-pressure lines, and innovation in smart contrast delivery systems.

The increasing number of imaging procedures is contributing to the growth of the contrast injection lines market. Imaging procedures are medical methods used to generate visual representations of internal body structures, which assist in the diagnosis, monitoring, and treatment of various health conditions. The rise in these procedures is largely due to the growing prevalence of chronic diseases, which require accurate and ongoing internal assessments for effective care. Contrast injection lines play a key role in these procedures by delivering contrast agents in a controlled and precise manner, enhancing the clarity of tissues, blood vessels, and other abnormalities during scans. This improves the accuracy of diagnoses and the efficiency of workflows, while also minimizing manual handling and supporting safer, contamination-free administration. For example, in May 2023, the National Health Service in the United Kingdom reported that the number of brain magnetic resonance imaging procedures referred by general practitioners increased from 8,695 in January 2022 to 8,745 in January 2023. This growth in imaging procedures is helping to drive demand for contrast injection lines.

Companies in this market are focusing on technological innovation, such as the development of advanced magnetic resonance imaging contrast media injectors, to improve imaging precision and workflow performance. These injectors are specialized devices designed to automatically deliver contrast agents into a patient's bloodstream during magnetic resonance imaging, enhancing the visibility of internal structures in the scanned images. In May 2025, Bracco Diagnostics Inc., a radiology company based in the United States, introduced the Max 3 syringeless injector system to improve both safety and efficiency in contrast media delivery. This system allows direct injection from contrast media vials without the need for syringes, enabling quicker patient transitions and reducing material waste. It functions wirelessly within magnetic resonance imaging environments up to 50 millitesla magnetic fields, offering flexible placement and secure, contamination-resistant connections through its Easy-Click Cassette and SafeConnect technology. The system is designed to support greater workflow efficiency, increase patient safety, and promote environmental responsibility in the administration of contrast agents during MRI procedures.

In November 2022, GE Healthcare Technologies Inc., a health technology company based in the United States, entered into a partnership with Ulrich GmbH and Company KG. The purpose of this collaboration is to improve efficiency in computed tomography imaging through the use of syringeless contrast media injectors that reduce waste and support higher patient throughput in the United States. Ulrich GmbH and Company KG is a technology company based in Germany that specializes in the development and production of contrast injector systems.

Major players in the contrast injection lines market are Bayer AG, GE Healthcare Technologies Inc., Bracco Imaging S.p.A., Merit Medical Systems Inc., Guerbet Group, B. Braun SE, ACIST Medical Systems Inc., ulrich medical, Sino Medical-Device Technology Co. Ltd., VIVID Imaging Pvt. Ltd., Medex, Hemant Surgical Industries Limited, Medtron AG, Argon Medical Devices Inc., Apollo RT, George Philips Medical Engineering Pvt. Ltd., Nemoto Kyorindo Co. Ltd., Sequoia Healthcare Limited, Shenzhen Anke High-Tech Co. Ltd., Shenzhen Kenid Medical Devices Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd.

North America was the largest region in the contrast injection lines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in contrast injection lines report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the contrast injection lines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The contrast injection lines market consists of sales of Y-connector tubing sets, check valve tubing lines, high-pressure extension lines, catheters, and related accessories used for delivering contrast agents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contrast Injection Lines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contrast injection lines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for contrast injection lines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contrast injection lines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: High Pressure Contrast Injection Line; Low Pressure Contrast Injection Line
  • 2) By Product Type: Non-Ionic Contrast Media; Ionic Contrast Media; Barium-Based Contrast Agents; Gadolinium-Based Contrast Agents
  • 3) By Route Of Administration: Intravenous Injection; Intra-Arterial Injection; Oral Administration; Intrathecal Injection
  • 4) By Application: Magnetic Resonance Imaging Examination; X-Ray Examination; Computed Tomography (CT) Examination; Angiography; Other Applications
  • 5) By End-User: Hospitals; Diagnostic Imaging Centers; Specialty Clinics; Research Institutions
  • Subsegments:
  • 1) By High Pressure Contrast Injection: Angiographic High Pressure Lines; Disposable High Pressure Lines; Dual Chamber High Pressure Lines
  • 2) By Low Pressure Contrast Injection Line: Manual Injection Lines; Reusable Low Pressure Lines; Syringe Based Low Pressure Lines
  • Companies Mentioned: Bayer AG; GE Healthcare Technologies Inc.; Bracco Imaging S.p.A.; Merit Medical Systems Inc.; Guerbet Group; B. Braun SE; ACIST Medical Systems Inc.; ulrich medical; Sino Medical-Device Technology Co. Ltd.; VIVID Imaging Pvt. Ltd.; Medex; Hemant Surgical Industries Limited; Medtron AG; Argon Medical Devices Inc.; Apollo RT; George Philips Medical Engineering Pvt. Ltd.; Nemoto Kyorindo Co. Ltd.; Sequoia Healthcare Limited; Shenzhen Anke High-Tech Co. Ltd.; Shenzhen Kenid Medical Devices Co. Ltd.; Shenzhen Basda Medical Apparatus Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Contrast Injection Lines Market Characteristics

3. Contrast Injection Lines Market Trends And Strategies

4. Contrast Injection Lines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Contrast Injection Lines Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Contrast Injection Lines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Contrast Injection Lines Market Growth Rate Analysis
  • 5.4. Global Contrast Injection Lines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Contrast Injection Lines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Contrast Injection Lines Total Addressable Market (TAM)

6. Contrast Injection Lines Market Segmentation

  • 6.1. Global Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High Pressure Contrast Injection Line
  • Low Pressure Contrast Injection Line
  • 6.2. Global Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Ionic Contrast Media
  • Ionic Contrast Media
  • Barium-Based Contrast Agents
  • Gadolinium-Based Contrast Agents
  • 6.3. Global Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous Injection
  • Intra-Arterial Injection
  • Oral Administration
  • Intrathecal Injection
  • 6.4. Global Contrast Injection Lines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Magnetic Resonance Imaging Examination
  • X-Ray Examination
  • Computed Tomography (CT) Examination
  • Angiography
  • Other Applications
  • 6.5. Global Contrast Injection Lines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Clinics
  • Research Institutions
  • 6.6. Global Contrast Injection Lines Market, Sub-Segmentation Of High Pressure Contrast Injection Line, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Angiographic High Pressure Lines
  • Disposable High Pressure Lines
  • Dual Chamber High Pressure Lines
  • 6.7. Global Contrast Injection Lines Market, Sub-Segmentation Of Low Pressure Contrast Injection Line, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Injection Lines
  • Reusable Low Pressure Lines
  • Syringe Based Low Pressure Lines

7. Contrast Injection Lines Market Regional And Country Analysis

  • 7.1. Global Contrast Injection Lines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Contrast Injection Lines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Contrast Injection Lines Market

  • 8.1. Asia-Pacific Contrast Injection Lines Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Contrast Injection Lines Market

  • 9.1. China Contrast Injection Lines Market Overview
  • 9.2. China Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Contrast Injection Lines Market

  • 10.1. India Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Contrast Injection Lines Market

  • 11.1. Japan Contrast Injection Lines Market Overview
  • 11.2. Japan Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Contrast Injection Lines Market

  • 12.1. Australia Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Contrast Injection Lines Market

  • 13.1. Indonesia Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Contrast Injection Lines Market

  • 14.1. South Korea Contrast Injection Lines Market Overview
  • 14.2. South Korea Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Contrast Injection Lines Market

  • 15.1. Western Europe Contrast Injection Lines Market Overview
  • 15.2. Western Europe Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Contrast Injection Lines Market

  • 16.1. UK Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Contrast Injection Lines Market

  • 17.1. Germany Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Contrast Injection Lines Market

  • 18.1. France Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Contrast Injection Lines Market

  • 19.1. Italy Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Contrast Injection Lines Market

  • 20.1. Spain Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Contrast Injection Lines Market

  • 21.1. Eastern Europe Contrast Injection Lines Market Overview
  • 21.2. Eastern Europe Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Contrast Injection Lines Market

  • 22.1. Russia Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Contrast Injection Lines Market

  • 23.1. North America Contrast Injection Lines Market Overview
  • 23.2. North America Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Contrast Injection Lines Market

  • 24.1. USA Contrast Injection Lines Market Overview
  • 24.2. USA Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Contrast Injection Lines Market

  • 25.1. Canada Contrast Injection Lines Market Overview
  • 25.2. Canada Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Contrast Injection Lines Market

  • 26.1. South America Contrast Injection Lines Market Overview
  • 26.2. South America Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Contrast Injection Lines Market

  • 27.1. Brazil Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Contrast Injection Lines Market

  • 28.1. Middle East Contrast Injection Lines Market Overview
  • 28.2. Middle East Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Contrast Injection Lines Market

  • 29.1. Africa Contrast Injection Lines Market Overview
  • 29.2. Africa Contrast Injection Lines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Contrast Injection Lines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Contrast Injection Lines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Contrast Injection Lines Market Competitive Landscape And Company Profiles

  • 30.1. Contrast Injection Lines Market Competitive Landscape
  • 30.2. Contrast Injection Lines Market Company Profiles
    • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bracco Imaging S.p.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Guerbet Group Overview, Products and Services, Strategy and Financial Analysis

31. Contrast Injection Lines Market Other Major And Innovative Companies

  • 31.1. B. Braun SE
  • 31.2. ACIST Medical Systems Inc.
  • 31.3. ulrich medical
  • 31.4. Sino Medical-Device Technology Co. Ltd.
  • 31.5. VIVID Imaging Pvt. Ltd.
  • 31.6. Medex
  • 31.7. Hemant Surgical Industries Limited
  • 31.8. Medtron AG
  • 31.9. Argon Medical Devices Inc.
  • 31.10. Apollo RT
  • 31.11. George Philips Medical Engineering Pvt. Ltd.
  • 31.12. Nemoto Kyorindo Co. Ltd.
  • 31.13. Sequoia Healthcare Limited
  • 31.14. Shenzhen Anke High-Tech Co. Ltd.
  • 31.15. Shenzhen Kenid Medical Devices Co. Ltd.

32. Global Contrast Injection Lines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contrast Injection Lines Market

34. Recent Developments In The Contrast Injection Lines Market

35. Contrast Injection Lines Market High Potential Countries, Segments and Strategies

  • 35.1 Contrast Injection Lines Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Contrast Injection Lines Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Contrast Injection Lines Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer